Nanoviricides Story

NNVC -- USA Stock

USD 4.16 0.03 0.73%

Macroaxis Story

The stock is undergoing an active upward rally. Because some of us are getting excited about healthcare space, it makes sense to go over NanoViricides Inc NEW in greater detail. We will evaluate if NanoViricides Inc shares are reasonably priced given the current economic outlook.

Published over a month ago

View all stories for Nanoviricides | View All Stories

Do analysts believe NanoViricides Inc (NYSEMKT:NNVC) will continue to rise?

NanoViricides Inc is UNDERVALUED at 5.95 per share with modest projections ahead. We provide investment recommendation to complement the last-minute expert consensus on NanoViricides Inc NEW. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time.

What is the right price you would pay to acquire a share of Nanoviricides? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated.

Please read more on our stock advisor page.

How important is Nanoviricides's Liquidity

Nanoviricides financial leverage refers to using borrowed capital as a funding source to finance Nanoviricides ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Nanoviricides financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Nanoviricides's total debt and its cash.

How Nanoviricides utilizes its cash?

To perform a cash flow analysis of Nanoviricides, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Nanoviricides is receiving and how much cash it distributes out in a given period. The Nanoviricides cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Nanoviricides Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (6 Million)

Payment of 38472 shares by Eugene Seymour of NanoViricides Inc subject to Rule 16b-3

Legal trades by Nanoviricides insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

NanoViricides insider trading alert for payment of common stock par value $0.001 per share by Eugene Seymour, Chief Executive Officer, on 14th of December 2020. This event was filed by Nanoviricides Inc with SEC on 2015-09-24. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Is NanoViricides a risky opportunity?

Let's check the volatility. NanoViricides is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind NanoViricides (NYSEMKT:NNVC) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. taking in a share of a NanoViricides Inc stock makes you a part-owner of that company.

Can NanoViricides Inc build up on the current rise?

Current Jensen Alpha is up to -0.06. Price may slip again. NanoViricides Inc NEW shows above-average downside volatility for the selected time horizon. We advise investors to inspect NanoViricides Inc NEW further and ensure that all market timing and asset allocation strategies are consistent with the estimation of NanoViricides Inc future alpha.

Our Final Take On NanoViricides Inc

Whereas other companies within the biotechnology industry are still a little expensive, even after the recent corrections, NanoViricides Inc may offer a potential longer-term growth to investors. To conclude, as of the 22nd of January 2021, our current 30 days buy-hold-sell recommendation on the company is Hold. We believe NanoViricides Inc is undervalued with very small probability of financial unrest for the next two years.

About Contributor

Achuva Shats is a Member of Macroaxs Editorial Board. Achuva writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Nanoviricides. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC